Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Farnesyltransferase-Mediated Delivery of a Covalent Inhibitor Overcomes Alternative Prenylation to Mislocalize K-Ras
  2. Novotny, Chris J.; Hamilton, Gregory L.; McCormick, Frank; Shokat, Kevan M.
  3. ACS CHEMICAL BIOLOGY. 2017, Jul; 12(7): 1956-1962.
  1. 2.   Structural studies of vacuolar plasmepsins
  2. Bhaumik, P.; Gustchina, A.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2012, Jan; 1824(1): 207-223.
  1. 3.   The Role of Amino-Terminal Sequences in Cellular Localization and Antiviral Activity of APOBEC3B
  2. Pak, V.; Heidecker, G.; Pathak, V. K.; Derse, D.
  3. Journal of Virology. 2011, Sep; 85(17): 8538-8547.
  1. 4.   Utilization of Nitrophenylphosphates and Oxime-Based Ligation for the Development of Nanomolar Affinity Inhibitors of the Yersinia pestis Outer Protein H (YopH) Phosphatase
  2. Bahta, M.; Lountos, G. T.; Dyas, B.; Kim, S. E.; Ulrich, R. G.; Waugh, D. S.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2011, Apr; 54(8): 2933-2943.
  1. 5.   Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain
  2. Wexler-Cohen, Y.; Ashkenazi, A.; Viard, M.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2010, Nov; 24(11): 4196-4202.
  1. 6.   Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41
  2. Gustchina, E.; Li, M.; Louis, J. M.; Anderson, D. E.; Lloyd, J.; Frisch, C.; Bewley, C. A.; Gustchina, A.; Wlodawer, A.; Clore, G. M.
  3. Plos Pathogens. 2010, Nov; 6(11): 19.
  1. 7.   A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex
  2. Jacobs, A.; Quraishi, O.; Huang, X. C.; Bousquet-Gagnon, N.; Nault, G.; Francella, N.; Alvord, W. G.; Pham, N.; Soucy, C.; Robitaille, M.; Bridon, D.; Blumenthal, R.
  3. Journal of Biological Chemistry. 2007, Nov; 282(44): 32406-32413.
  1. 8.   theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation
  2. Gallo, S. A.; Wang, W.; Rawat, S. S.; Jung, G.; Waring, A. J.; Cole, A. M.; Lu, H.; Yan, X. X.; Daly, N. L.; Craik, D. J.; Jiang, S. B.; Lehrer, R. I.; Blumenthal, R.
  3. Journal of Biological Chemistry. 2006, Jul; 281(27): 18787-18792.
  1. 9.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 10.   New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies
  2. De Martino, G.; Edler, M. C.; La Regina, G.; Coluccia, A.; Barbera, M. C.; Barrow, D.; Nicholson, R. I.; Chiosis, G.; Brancale, A.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 947-954.
  1. 11.   Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A
  2. Park, J. G.; Sill, P. C.; Makiyi, E. F.; Garcia-Sosa, A. T.; Millard, C. B.; Schmidt, J. J.; Pang, Y. P.
  3. Bioorganic & Medicinal Chemistry. 2006, Jan; 14(2): 395-408.
  1. 12.   Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis
  2. Dorjsuren, D.; Burnette, A.; Gray, G. N.; Chen, X. L.; Zhu, W. M.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S.
  3. Antiviral Research. 2006, JAN; 69(1): 9-23.
  1. 13.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 14.   Structure-based discovery of a boronic acid bioisostere of combretastatin A-4
  2. Kong, Y.; Grembecka, J.; Edler, M. C.; Hamel, E.; Mooberry, S. L.; Sabat, M.; Rieger, J.; Brown, M. L.
  3. Chemistry & Biology. 2005, SEP; 12(9): 1007-1014.
  1. 15.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 16.   Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-4
  2. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Hamel, E.; Schmidt, J. M.; Pettitt, R. K.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 4087-4099.
  1. 17.   Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q. E.; Stephen, A. G.; Adelsberger, J. W.; Roberts, P. E.; Zhu, W. M.; Currens, M. J.; Feng, Y. X.; Crise, B. J.; Gorelick, R. J.; Rein, A. R.; Fisher, R. J.; Shoemaker, R. H.; Sei, S.
  3. Journal of Virology. 2005, MAY; 79(10): 6122-6133.
  1. 18.   Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia
  2. Lemaire, M.; Momparler, L. F.; Bernstein, M. L.; Marquez, V. E.; Momparler, R. L.
  3. Anti-Cancer Drugs. 2005, MAR; 16(3): 301-308.
  1. 19.   Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase
  2. Liu, Y. S.; Shreder, K. R.; Gai, W. Z.; Corral, S.; Ferris, D. K.; Rosenblum, J. S.
  3. Chemistry & Biology. 2005, JAN; 12(1): 99-107.
  1. 20.   Arylthioindoles, potent inhibitors of tubulin polymerization
  2. De Martino, G.; La Regina, G.; Coluccia, A.; Edler, M. C.; Barbera, M. C.; Brancale, A.; Wilcox, E.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2004, DEC 2; 47(25): 6120-6123.
  1. 21.   Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide - Possible recognition of the fusion complex
  2. Gerber, D.; Pritsker, M.; Gunther-Ausborn, S.; Johnson, B.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004, NOV 12; 279(46): 48224-48230.
  1. 22.   A 4 '-C-ethynyl-2 ',3 '-dideoxynucleoside analogue highlights the role of the 3 '-OH in anti-HIV active 4 '-C-ethynyl-2 '-deoxy nucleosides
  2. Siddiqui, M. A.; Hughes, S. H.; Boyer, P. L.; Mitsuya, H.; Van, Q. N.; George, C.; Sarafinanos, S. G.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5041-5048.
  1. 23.   The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. MacDonald, C. J.; Ciolino, H. P.; Yeh, G. C.
  3. Cancer Research. 2004 64(1): 429-434.
  1. 24.   Lipidic inhibitors of human N-myristoyltransferase
  2. Pasha, M. K.; Selvakumar, P.; Ashakumary, L.; Qureshi, M.; Guziec, F. S.; Dimmock, J. R.; Felsted, R. L.; Glover, C. J.; Sharma, R. K.
  3. International Journal of Molecular Medicine. 2004 13(4): 557-563.
  1. 25.   Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions
  2. Svarovskaia, E. S.; Barr, R.; Zhang, X. C.; Pais, G. C. G.; March, C.; Pommier, Y.; Burke, T. R.; Pathak, V. K.
  3. Journal of Virology. 2004 78(7): 3210-3222.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel